| __timestamp | Alnylam Pharmaceuticals, Inc. | Ascendis Pharma A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 13983000 |
| Thursday, January 1, 2015 | 41097000 | 8118000 |
| Friday, January 1, 2016 | 47159000 | 4606000 |
| Sunday, January 1, 2017 | 76545000 | 1530000 |
| Monday, January 1, 2018 | 73106000 | 10581000 |
| Tuesday, January 1, 2019 | 194688000 | 13375000 |
| Wednesday, January 1, 2020 | 414801000 | 6953000 |
| Friday, January 1, 2021 | 704143000 | 4255000 |
| Saturday, January 1, 2022 | 868601000 | 39037000 |
| Sunday, January 1, 2023 | 1517886000 | 222323000 |
| Monday, January 1, 2024 | 1924873000 | 319383000 |
Data in motion
In the dynamic world of biotechnology, Alnylam Pharmaceuticals, Inc. and Ascendis Pharma A/S have carved distinct paths over the past decade. Alnylam, a leader in RNA interference therapeutics, has seen its gross profit skyrocket by over 2,900% from 2014 to 2023. This remarkable growth underscores its successful commercialization strategies and robust pipeline.
Conversely, Ascendis Pharma, specializing in innovative prodrug therapies, has experienced a more modest increase in gross profit, growing by approximately 1,500% in the same period. While Ascendis's growth trajectory is less steep, its strategic focus on long-term, sustainable development is evident.
The data reveals a compelling narrative of two companies navigating the biotech landscape with distinct strategies. As Alnylam continues to capitalize on its early market entry, Ascendis's steady progress suggests a promising future in the competitive biotech arena.
Key Insights on Gross Profit: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Gross Profit Comparison: Merck & Co., Inc. and Ascendis Pharma A/S Trends
Bristol-Myers Squibb Company vs Ascendis Pharma A/S: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.
Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc. Trends
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Ascendis Pharma A/S
Dr. Reddy's Laboratories Limited and Ascendis Pharma A/S: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ascendis Pharma A/S and Amneal Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Ascendis Pharma A/S vs Travere Therapeutics, Inc.